# Aldosterone and Vascular Disease in Diabetes Mellitus

> **NCT00214825** · NA · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 46 (actual)

## Conditions studied

- Diabetes Mellitus
- Endothelial Dysfunction
- Albuminuria

## Interventions

- **DRUG:** eplerenone
- **DRUG:** Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00214825
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2008-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214825, "Aldosterone and Vascular Disease in Diabetes Mellitus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00214825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*